Two studies presented at EADV 2026 highlight misinformation and dermatologic complications linked to viral skincare routines on social media.
|Articles|July 28, 2014
Talking about preservatives with patients
Expert offers talking points for when patients ask about preservatives in skincare and haircare products.
Advertisement
Beth Lange, Ph.D., executive vice president, chief scientist, The Personal Care Products Council
Beth Lange, Ph.D., chief scientist, Personal Care Products Council, offers dermatologists these talking points when patients ask about preservatives in skincare and haircare products.
- Preservatives are an incredibly critical component of hair and skin care products. They not only help preserve the integrity of the product but also keep the active ingredients in a form that are still fresh and available for consumers using those products.
- When you look at parabens, in particular, parabens have been around for more than 100 years, and they’re not only used in cosmetics, but also foods and medicine. They are naturally occurring in blueberries, cucumbers and many other fruits and vegetables.
- The parabens used in cosmetics are identical to what we find in nature.
- The concerns about parabens come from the non-scientific community, speculating there could be a connection between parabens and cancer because of endocrine disruption. There are no scientific studies that support grounds for this. Any interaction between parabens and endocrine disruption is thousands of times weaker with skin and hair care products than from the fruits and vegetables in which they naturally occur.
- The most important message is: preservatives are critical for the shelf life of the product, the safety of the product and the stability of the actives. You don’t want to be exposing yourself unnecessarily to bacteria, yeast or mold, because of a products that’s not well preserved.
More articles in our package on OTC product ingredients:
Advertisement
Related to this article
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of September.
Though convenient, SPF-infused cosmetics rarely deliver their labeled protection level in real-world use, underscoring the continued need for a dedicated broad-spectrum sunscreen as the foundation of any routine.
A new report from the National Eczema Association (NEA) found systemic corticosteroids were filled more often than dupilumab, and 13% of Americans live in counties without a dermatology or allergy/immunology practitioner.
Real-world EADV 2026 data suggest autonomous AI could increase dermatology capacity while maintaining high sensitivity for invasive skin cancers.
Up to 72% of tulisokibart-treated patients achieved HiSCR50 at week 16 vs 35% with placebo, the first positive phase 2 anti-TL1A data in dermatology.
Treatment success reached 56.7% and total lesions fell 71.8% with up to 52 weeks of oral denifanstat, with no adverse event-related discontinuations.
Advertisement
Advertisement
Trending on Dermatology Times
1
Daxdilimab Improves Disease Activity in Treatment-Refractory Discoid Lupus in Phase 2 Trial
2
Late Breaking: Zumilokibart Meets Primary End Point in Phase 2 Atopic Dermatitis Trial
3
Nearly 95% of Viral Korean Skincare TikTok Videos Contain Misleading Claims
4
Nemolizumab Sustains Atopic Dermatitis Responses Through 3 Years in ARCADIA
5